BioCentury
ARTICLE | Company News

Akzo Nobel NV, Fabre-Kramer Pharmaceuticals Inc. deal

June 20, 2005 7:00 AM UTC

Fabre-Kramer reacquired marketing rights to depression compound gepirone ER from AKZ's Organon subsidiary (Oss, the Netherlands). In 2004, the partial serotonin (5-HT1A) receptor agonist received a n...